International Kidney Cancer Collaboration with Leadership from Philadelphia

Kidney cancer is a growing global health problem, and both clinicians and policymakers need to prepare for a steep rise in the number of cases,” said Alexander Kutikov, MD, FACS, Chair of the Department of Urology at Fox Chase Cancer Center, and senior author of a landmark international study published in European Urology, which demonstrates that if current trends continue, kidney cancer cases could double by 2050

By
December 2, 2025
3 min

Fox Chase Cancer Center

Top Institutions in Urology

Brief introduction explaining scope and methodology.

#1

Fox Chase Cancer Center – Temple University Health System

Philadelphia, PA
Key Differentiators
- Urologic Oncology
- Kidney Cancer Research
- Surgical Oncology
#2

Memorial Sloan Kettering Cancer Center

New York, NY
Key Differentiators
- Urologic Oncology
- Kidney Cancer Surgery
- Cancer Genomics
#3

Mayo Clinic

Rochester, MN
Key Differentiators
- Urologic Oncology
- Kidney Cancer Clinical Trials
- Genetic Epidemiology
#4

Dana-Farber/Brigham and Women’s Cancer Center

Boston, MA
Key Differentiators
- Medical Oncology
- Kidney Cancer Research
- Translational Medicine
#5

University of California, San Francisco (UCSF) Medical Center

San Francisco, CA
Key Differentiators
- Urologic Oncology
- Kidney Cancer Surgery
- Genomic Medicine